# Steven M. Haffner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/steven-m-haffner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 90,058 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 141 |
| i10-index | 510 |
| OpenAlex ID | https://openalex.org/A5108086045 |
| Works | 599 |

## Researcher papers

- [Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy](https://scholariq.org/papers/glycemic-durability-of-rosiglitazone-metformin-or-glyburide-monotherapy/)
- [Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events](https://scholariq.org/papers/clopidogrel-and-aspirin-versus-aspirin-alone-for-the-prevention-of/)
- [Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study](https://scholariq.org/papers/metabolic-syndrome-with-and-without-c-reactive-protein-as-a-predictor-of/)
- [Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes](https://scholariq.org/papers/cardiorenal-end-points-in-a-trial-of-aliskiren-for-type-2-diabetes/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.